Biliary Tract Cancer Clinical Trials

274 clinical trials for Biliary Tract Cancer across international registries, including 68 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies — RECRUITING · PHASE1
• Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) — RECRUITING · PHASE2
• AB122 Platform Study — RECRUITING · PHASE1
• D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer — RECRUITING · PHASE3
• QL1706（Iparomlimab/Tuvonralimab) Combined With Gemcitabine and Cisplatin as First-Line Treatment for PD-L1-Positive Biliary Tract Cancer — RECRUITING · PHASE2
• AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 — RECRUITING · PHASE2
• Study on Sequential Cryoablation, Relaforp Alpha, and Chemotherapy for Bile Duct Tumors — RECRUITING · PHASE2
• A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally Advanced or Metastatic Biliary Tract Cancer After Failure of Platinum-based Chemotherapy(PANKU-BTC01) — RECRUITING · PHASE3
• A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure — RECRUITING · PHASE3
• Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors — RECRUITING · PHASE1
• A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02) — RECRUITING · PHASE3
• Futibatinib (TAS-120) in Patients With Advanced Biliary Tract Cancer — RECRUITING · PHASE3
• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer — RECRUITING · PHASE3
• Hepatic Arterial Infusion Chemotherapy Plus Envafolimab and Lenvatinib for First-Line Unresectable Advanced Biliary Tract Cancer — RECRUITING · PHASE1
• Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) — RECRUITING · PHASE1
• Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer — RECRUITING · PHASE3
• A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) — RECRUITING · PHASE1
• A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer — RECRUITING · PHASE3
• Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients — RECRUITING · NA
• Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer — RECRUITING · PHASE1
• A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies — RECRUITING · PHASE1
• CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors — RECRUITING · PHASE1
• Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients — RECRUITING · PHASE2
• AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) — RECRUITING · PHASE1
• HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer — RECRUITING · NA
• Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer — RECRUITING · PHASE2
• Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers — RECRUITING
• HX009+ IN10018 With or Without Standard Chemotherapy for Advanced Solid Tumours — RECRUITING · PHASE1
• A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer — RECRUITING · PHASE1
• Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC — RECRUITING · PHASE2
• This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Trastuzumab in Combination With Serplulimab and Chemotherapy for the Treatment of HER2-overexpressing Unresectable Locally Advanced or Metastatic Biliary Tract Cancer or Urothelial Carcinoma After Failure of Standard Therapy — RECRUITING · PHASE2
• A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer — RECRUITING · PHASE2
• Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab — RECRUITING
• Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC — RECRUITING
• ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer — RECRUITING
• Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer — RECRUITING · PHASE1
• A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy — RECRUITING
• Ligufalimab and Cadonilimab in Advanced Liver Cancers — RECRUITING · PHASE2
• Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes — RECRUITING · NA
• Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer — RECRUITING · PHASE2
• A Phase 1 Study of LNCB74 in Advanced Solid Tumors — RECRUITING · PHASE1
• An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy. — RECRUITING · PHASE2
• The Study of Association of Helicobacter Infections in Biliary Tract Cancers — RECRUITING
• A Study of MT-4561 in Patients With Various Advanced Solid Tumors — RECRUITING · PHASE1
• Chemoimmunotherapy Combined With Hyperthermia and Spatially-Fractionated Radiotherapy in Advanced Biliary Tract Cancer — RECRUITING · PHASE1
• Tuvonralimab and Iparomlimab Based Regimens for the Neoadjuvant Treatment of Biliary Tract Cancer — RECRUITING · PHASE2
• Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery — RECRUITING · NA

Refine this search